Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 2/11/2025JNJ Receives Approval in China for Two Novel BsAbs
  • 2/11/2025CARsgen's First Subject in THANK-u Plus™ Allogeneic CAR-T Trial Achie...
  • 2/11/2025China's Digital Health Sector Poised for Growth Amid Data Security Con...
  • 2/11/2025Bio-Thera Enters License Pact with Intas Pharma for Simponi® Biosim...
  • 2/11/2025Novo Nordisk Reports Strong Growth in China for 2024, Driven by GLP-1 ...
  • 2/11/2025Regend Secures Series B+ Financing to Advance Stem Cell-Based Regenera...
  • 2/11/2025XtalPi Announces Strategic Investment and Collaboration with Alternati...
  • 2/10/2025Kelun-Biotech's Cetuximab Biosimilar Receives NMPA Approval for First-...
  • 2/10/2025Hexaell Biotech Completes CNY 200M Series B+ Financing to Accelerate L...
  • 2/7/2025Henlius and Dr. Reddy's Ink Licensing Deal for Daratumumab Biosimilar ...
  • 2/7/2025AstraZeneca Reports Strong 2024 Performance Amid China Sales Decline a...
  • 2/6/2025Roche Reports Strong 2024 Growth with China Sales Reaching $6.1 Billio...
  • 2/6/2025GSK Faces Vaccine Challenges in China Amid Market Pressures
  • 2/5/2025 Pfizer Eyes Expansion in China Amid Pipeline Reshuffle
  • 2/5/2025Merck Faces Growing Challenges in China as Gardasil Sales Stall  
  • 2/2/2025Vigonvita Life Sciences Submits IPO Application to Hong Kong Stock Exc...
  • 2/2/2025ImmunityBio and BeiGene Partner on Phase 3 Trial of ANKTIVA and PD-1 I...
  • 2/2/2025I-Mab Cuts 27% of Workforce Amid Strategic Shift
  • 1/28/2025China's Evolving Role in Pharma Spurs Regional Realignments, Boosts In...
  • 1/28/2025InnoCare's Efsubaglutide Alfa Receives Approval in China for Type 2 Di...
  • 1/28/2025CStone Partners with SteinCares to Market Sugemalimab in Latin America
  • 1/27/2025AsiFlyer Secures Series Pre-A++ Funding to Advance Botulinum Toxin Dru...
  • 1/27/2025GeneQuantum Announces Strategic Collaborations with Biohaven and Aimed...
  • 1/27/2025Lumiere Secures Series Pre-A Funding to Advance Gene Editing Research
  • 1/24/2025Ab&B Biotech Submits IPO Application to Hong Kong Stock Exchange
  • 1/24/2025Hengrui's Insulin Degludec BLA Accepted by China's NMPA
  • 1/23/2025TargetRx Secures $50 Million in Series C Financing to Propel Global Cl...
  • 1/23/2025Belief BioMed Announces IND Clearance by FDA for DMD Gene Therapy Cand...
  • 1/22/2025Degron Secures $20M in Series A+ Financing to Advance Molecular Glue T...
  • 1/22/2025Imbioray Secures Series A+ Financing to Advance NK Cell Therapy Pipeli...
  • Page:12/24 Total number of articles:711: [First][<<] [10] [11] [12] [13] [14] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group